Concepedia

Fengtao You

FY

13

Publications

1K

Citations

12

H-Index

2016

Active since

Affiliations

PersonGen (China)(Current)

Soochow University

First Affiliated Hospital of Zhengzhou University

Peking University

First Affiliated Hospital of Soochow University

Fengtao You is an author at PersonGen (China) specializing in t cell immunity, immunology, and medicine.

Top concepts

Publications per year

2016–2024

13

Publications

13

Erratum: First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia.

Xiaowen Tang, Lin Yang, Zheng Li et al. · PubMed · 2018 · 412 citations · Full text

Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells

Fengtao You, Licui Jiang, Bozhen Zhang et al. · Science China Life Sciences · 2016 · 148 citations · Full text

A novel CD7 chimeric antigen receptor-modified NK-92MI cell line targeting T-cell acute lymphoblastic leukemia.

Fengtao You, Yinyan Wang, Licui Jiang et al. · PubMed · 2019 · 130 citations · Full text

, , +19

Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed and Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma

Mingzhi Zhang, Dan Chen, Xiaorui Fu et al. · Clinical Cancer Research · 2022 · 105 citations · Full text

<p>Decitabine enhances cytotoxic effect of T cells with an anti-CD19 chimeric antigen receptor in treatment of lymphoma</p>

Sujun Li, Lei Xue, Min Wang et al. · OncoTargets and Therapy · 2019 · 54 citations · Full text

Rows per page

1–5 of 13